Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha

Arthritis Rheum. 1993 Jun;36(6):790-4. doi: 10.1002/art.1780360608.

Abstract

Objective: To investigate the production of leukemia inhibitory factor (LIF) by human articular chondrocytes and cartilage.

Methods: Chondrocytes and cartilage were cultured with and without added cytokines, and the conditioned media assayed for LIF by a specific radioreceptor competition assay.

Results: Interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF alpha) stimulated LIF production by chondrocyte monolayers and cartilage. LIF was generally not detected in unstimulated cultures. Northern blot analysis showed increased amounts of LIF messenger RNA in IL-1- and TNF alpha-treated chondrocyte cultures.

Conclusion: Chondrocytes, stimulated by IL-1 and/or TNF alpha, are potential contributors to the elevated levels of LIF observed in the synovial fluids of patients with rheumatoid arthritis and other inflammatory arthritides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Arthritis, Rheumatoid / pathology
  • Cartilage / metabolism*
  • Cartilage, Articular / cytology*
  • Cartilage, Articular / metabolism*
  • Cells, Cultured
  • Cytokines / pharmacology
  • Growth Inhibitors / genetics
  • Growth Inhibitors / metabolism*
  • Growth Inhibitors / physiology
  • Humans
  • Interleukin-1 / pharmacology*
  • Interleukin-6*
  • Leukemia Inhibitory Factor
  • Lymphokines / genetics
  • Lymphokines / metabolism*
  • Lymphokines / physiology
  • Middle Aged
  • RNA, Messenger / analysis
  • Synovial Fluid / cytology
  • Transcription, Genetic / drug effects
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Cytokines
  • Growth Inhibitors
  • Interleukin-1
  • Interleukin-6
  • LIF protein, human
  • Leukemia Inhibitory Factor
  • Lymphokines
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha